Job Postings

Canada’s Island Garden, now operating under FIGR, is a pre-licence medical marihuana production, processing and distribution company located in the BioCommons Research Park, Charlottetown, PEI. The facility is comprised of 24,000 square feet with two floors dedicated to growing and processing medical marihuana – with more expansions currently in the works.

Canada’s Island Garden, now operating under FIGR, is a pre-licence medical marihuana production, processing and distribution company located in the BioCommons Research Park, Charlottetown, PEI. The facility is comprised of 24,000 square feet with two floors dedicated to growing and processing medical marihuana – with more expansions currently in the works.

Canada’s Island Garden, now operating under FIGR, is a pre-licence medical marihuana production, processing and distribution company located in the BioCommons Research Park, Charlottetown, PEI. The facility is comprised of 24,000 square feet with two floors dedicated to growing and processing medical marihuana – with more expansions currently in the works.

Synapse Applied Research and Industry Services (Synapse) is an independently-incorporated company. It was created to help transfer the expertise and knowledge housed in the University of Prince Edward Island (UPEI) into products, processes, services and insights that can provide practical social and economic benefit beyond the university environment.

Elanco Canada Ltd. is the animal health division of Eli Lily and Company. On PEI, the biotech pharmaceutical company manufactures vaccines for fish for customers from all over the world. PEI is home to a large manufacturing facility and Elanco’s Aquaculture R & D division.

Dosecann Inc. is a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets. They are currently completing the buildout of a 42,000 square foot GMP compliant facility in the PEI BioCommons Research Park in Charlottetown. Within the purpose-built facility, Dosecann will accommodate product development, extraction, formulation, filling and packaging.

The Centre for Aquaculture Technologies Canada is a contract research organization (CRO) providing support for R&D and commercialization activities in the aquaculture industry, with particular expertise in GxP-compliant research.

BioVectra Inc. is a leading bioscience business located in Prince Edward Island and Nova Scotia, focused on contract manufacturing and product development of active pharmaceutical ingredients, pharmaceutical intermediates, and bio-reagents. BioVectra is an industry leader in microbial fermentation, with 64,000 L of fermentation capacity.

Sekisui Diagnostics P.E.I. Inc. is a global leading manufacturer and developer of in-vitro diagnostics products, focused on bringing general and specialty clinical chemistry reagents to diagnostics manufacturers and clinical laboratories worldwide. Based in Japan, the company purchased an existing bioscience company in Charlottetown which each year, produces 1.5 billion clinical chemistry tests in P.E.I. that are then shipped around the world. Sekisui was named one of Canada’s top 100 Employers in 2018.

Sekisui Diagnostics P.E.I. Inc. is a global leading manufacturer and developer of in-vitro diagnostics products, focused on bringing general and specialty clinical chemistry reagents to diagnostics manufacturers and clinical laboratories worldwide. Based in Japan, the company purchased an existing bioscience company in Charlottetown which each year, produces 1.5 billion clinical chemistry tests in P.E.I. that are then shipped around the world. Sekisui was named one of Canada’s top 100 Employers in 2018.

Sekisui Diagnostics P.E.I. Inc. is a global leading manufacturer and developer of in-vitro diagnostics products, focused on bringing general and specialty clinical chemistry reagents to diagnostics manufacturers and clinical laboratories worldwide. Based in Japan, the company purchased an existing bioscience company in Charlottetown which each year, produces 1.5 billion clinical chemistry tests in P.E.I. that are then shipped around the world. Sekisui was named one of Canada’s top 100 Employers in 2018.

Sekisui Diagnostics P.E.I. Inc. is a global leading manufacturer and developer of in-vitro diagnostics products, focused on bringing general and specialty clinical chemistry reagents to diagnostics manufacturers and clinical laboratories worldwide. Based in Japan, the company purchased an existing bioscience company in Charlottetown which each year, produces 1.5 billion clinical chemistry tests in P.E.I. that are then shipped around the world. Sekisui was named one of Canada’s top 100 Employers in 2018.

Sekisui Diagnostics P.E.I. Inc. is a global leading manufacturer and developer of in-vitro diagnostics products, focused on bringing general and specialty clinical chemistry reagents to diagnostics manufacturers and clinical laboratories worldwide. Based in Japan, the company purchased an existing bioscience company in Charlottetown which each year, produces 1.5 billion clinical chemistry tests in P.E.I. that are then shipped around the world. Sekisui was named one of Canada’s top 100 Employers in 2018.

HZPC is a specialist in breeding, growing and marketing of seed potatoes, with a comprehensive range of new varieties available that meet requirements of modern lifestyles. The Company has undertaken an extensive program of variety trialing and introduction in most potato production regions of North America. HZPC Americas Corp. has a tissue culture laboraty for in-vitro plant propagation which forms the basis for seed potatoes grown by the best Canadian producers.

Dosecann Inc. is a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets. They are currently completing the buildout of a 42,000 square foot GMP compliant facility in the PEI BioCommons Research Park in Charlottetown. Within the purpose-built facility, Dosecann will accommodate product development, extraction, formulation, filling and packaging.

Dosecann Inc. is a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets. They are currently completing the buildout of a 42,000 square foot GMP compliant facility in the PEI BioCommons Research Park in Charlottetown. Within the purpose-built facility, Dosecann will accommodate product development, extraction, formulation, filling and packaging.

Dosecann Inc. is a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets. They are currently completing the buildout of a 42,000 square foot GMP compliant facility in the PEI BioCommons Research Park in Charlottetown. Within the purpose-built facility, Dosecann will accommodate product development, extraction, formulation, filling and packaging.

Dosecann Inc. is a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets. They are currently completing the buildout of a 42,000 square foot GMP compliant facility in the PEI BioCommons Research Park in Charlottetown. Within the purpose-built facility, Dosecann will accommodate product development, extraction, formulation, filling and packaging.

Sekisui Diagnostics P.E.I. Inc. is a global leading manufacturer and developer of in-vitro diagnostics products, focused on bringing general and specialty clinical chemistry reagents to diagnostics manufacturers and clinical laboratories worldwide. Based in Japan, the company purchased an existing bioscience company in Charlottetown which each year, produces 1.5 billion clinical chemistry tests in P.E.I. that are then shipped around the world. Sekisui was named one of Canada’s top 100 Employers in 2018.

Dosecann Inc. is a PEI-based Licensed Dealer developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets. They are currently completing the buildout of a 42,000 square foot GMP compliant facility in the PEI BioCommons Research Park in Charlottetown. Within the purpose-built facility, Dosecann will accommodate product development, extraction, formulation, filling and packaging.